Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 6794
Gene Symbol: STK11
STK11
0.410 GeneticVariation disease CLINVAR
Entrez Id: 6794
Gene Symbol: STK11
STK11
0.410 GenomicAlterations disease CGI
Entrez Id: 6794
Gene Symbol: STK11
STK11
0.410 CausalMutation disease CGI
Entrez Id: 6794
Gene Symbol: STK11
STK11
0.410 CausalMutation disease CLINVAR
Entrez Id: 3815
Gene Symbol: KIT
KIT
0.120 CausalMutation disease CLINVAR
Entrez Id: 8915
Gene Symbol: BCL10
BCL10
0.100 CausalMutation disease CLINVAR
Entrez Id: 2261
Gene Symbol: FGFR3
FGFR3
0.100 CausalMutation disease CLINVAR
Entrez Id: 1485
Gene Symbol: CTAG1B
CTAG1B
0.100 Biomarker disease BEFREE Cancer testis antigens (CTAs) are T-cell-defined tumor-associated antigens encoded by the genes and gene families such as MAGE, NY-ESO-1, and others. 15515159 2004
Entrez Id: 246100
Gene Symbol: CTAG1A
CTAG1A
0.100 Biomarker disease BEFREE Cancer testis antigens (CTAs) are T-cell-defined tumor-associated antigens encoded by the genes and gene families such as MAGE, NY-ESO-1, and others. 15515159 2004
Entrez Id: 54742
Gene Symbol: LY6K
LY6K
0.010 Biomarker disease BEFREE Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas. 18089789 2007
Entrez Id: 9043
Gene Symbol: SPAG9
SPAG9
0.040 Biomarker disease BEFREE Cancer testis antigen SPAG9 is a promising marker for the diagnosis and treatment of lung cancer. 26934841 2016
Entrez Id: 84692
Gene Symbol: CCDC54
CCDC54
0.050 Biomarker disease BEFREE Cancer testis antigen Sperm Protein 17 as a new target for triple negative breast cancer immunotherapy. 29088794 2017
Entrez Id: 53340
Gene Symbol: SPA17
SPA17
0.050 Biomarker disease BEFREE Cancer testis antigen Sperm Protein 17 as a new target for triple negative breast cancer immunotherapy. 29088794 2017
Entrez Id: 10761
Gene Symbol: PLAC1
PLAC1
0.020 Biomarker disease BEFREE Cancer/testis antigen-Plac1 promotes invasion and metastasis of breast cancer through Furin/NICD/PTEN signaling pathway. 29704427 2018
Entrez Id: 53340
Gene Symbol: SPA17
SPA17
0.050 Biomarker disease BEFREE Sp17 is therefore a novel member of the CT antigen family and should be an ideal target for immunotherapy of multiple myeloma. 11222401 2001
Entrez Id: 84692
Gene Symbol: CCDC54
CCDC54
0.050 Biomarker disease BEFREE Sp17 is therefore a novel member of the CT antigen family and should be an ideal target for immunotherapy of multiple myeloma. 11222401 2001
Entrez Id: 8900
Gene Symbol: CCNA1
CCNA1
0.010 AlteredExpression disease BEFREE Cyclin A1 is a tissue-specific cyclin that is highly expressed in acute myeloid leukemia and in testicular cancer. 14510182 2003
Entrez Id: 6406
Gene Symbol: SEMG1
SEMG1
0.020 Biomarker disease BEFREE Semenogelin 1 was also frequently coexpressed with other CT antigens, Sperm protein 17 and SPAN-Xb. 14595213 2004
Entrez Id: 7503
Gene Symbol: XIST
XIST
0.020 Biomarker disease BEFREE XIST unmethylated DNA fragments in male-derived plasma as a tumour marker for testicular cancer. 14723995 2004
Entrez Id: 246100
Gene Symbol: CTAG1A
CTAG1A
0.100 Biomarker disease BEFREE NY-ESO-1 is one of the most immunogenic cancer/testis (CT) antigens and emerges as the potential candidate for specific immunotherapy. 15069548 2004
Entrez Id: 1485
Gene Symbol: CTAG1B
CTAG1B
0.100 Biomarker disease BEFREE NY-ESO-1 is one of the most immunogenic cancer/testis (CT) antigens and emerges as the potential candidate for specific immunotherapy. 15069548 2004
Entrez Id: 51270
Gene Symbol: TFDP3
TFDP3
0.010 Biomarker disease BEFREE HCA661 is a novel cancer/testis (CT) antigen screened by SEREX from sera of an HCC patient. 15083197 2004
Entrez Id: 472
Gene Symbol: ATM
ATM
0.010 Biomarker disease BEFREE ATM activation in normal human tissues and testicular cancer. 15846060 2005
Entrez Id: 10566
Gene Symbol: AKAP3
AKAP3
0.030 Biomarker disease BEFREE A-kinase anchoring protein 3 (AKAP-3) is a novel member of the CT antigen family. 16005946 2005
Entrez Id: 56915
Gene Symbol: EXOSC5
EXOSC5
0.010 Biomarker disease BEFREE CML28, a recently discovered cancer-testis (CT) antigen from chronic myelogenous leukemia, is considered to be a promising target of tumor-specific immunotherapy. 16534571 2006